Search for: "Novartis Pharmaceuticals Corporation" Results 41 - 60 of 151
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2015, 2:20 pm by Tom Lamb
This September 2015 Drug Safety Alert Is Based Primarily On Reports Of Skin Cancer And Lymphoma Blood Cancer &nbsp (Posted by Tom Lamb at DrugInjuryWatch.com)   Health Canada recently conducted a review of safety information obtained from the drug company Novartis Pharmaceuticals Corporation, the manufacturer of Gilenya (fingolimod), about a potential link between the use of this multiple sclerosis (MS) drug and certain types of cancers and malignant tumors or… [read post]
6 Aug 2015, 2:08 pm by Tom Lamb
As regards the resulting August 2015 revision to the Gilenya Prescribing Information (also known as "package insert" and "drug label"), the FDA SUPPLEMENT APPROVAL letter (8/4/15) to Novartis Pharmaceuticals Corporation sets the stage: This supplemental application provides for addition of a new subsection to the Warnings and Precautions section of the prescribing information; the new subsection [5.3] describes the cases of progressive multifocal… [read post]
2 Mar 2015, 2:43 pm
ZTE Corporation is ramping up to take advantage of the new legal environment that has resulted from the settlement between Qualcomm and the Chinese National Development and Reform Commission (NDRC) over claims that the company’s licensing practices had violated the country’s Anti-Monopoly Law, recounts Neil.* Groundless threats to sue for IP infringement: the end of an era? [read post]
30 Jun 2014, 4:23 am by Lawrence B. Ebert
Milliken & Company Northrop Grumman Corporation Novartis Patent Café.com, Inc. [read post]
15 May 2014, 6:43 pm by Richard M.
Sun Pharmaceutical Industries made an announcement of a settlement deal with Novartis Pharmaceutical Corporation to disregard lawsuits filed against Sun Pharmaceutical on the launching of a generic form of Novartis’ own Gleevec. [read post]
18 Apr 2014, 11:00 am
Novartis Pharmaceuticals Corp., No. 13-15433, 2014 U.S. [read post]
18 Mar 2014, 9:13 am by Saurabh Anand
  In addition, in July 2010, FDA issued an untitled letter to Novartis Pharmaceuticals Corporation relating to the “Facebook Share” widget on its Tasigna® product website. [read post]
31 Dec 2013, 11:41 pm by Mark Summerfield
  In the US, the Court of Appeals for the Federal Circuit completely failed to come to terms with patent-eligibility of software-implemented inventions in the case of CLS Bank v Alice Corporation which is, as a consequence, now on its way to the Supreme Court.Australia’s High Court confirmed the patent-eligibility of methods of medical treatment, and in particular of methods for treating conditions using known pharmaceutical substances that have not previously been known… [read post]
6 Dec 2013, 3:14 pm
Switzerland also has a long history of social equality, and many citizens were offended by cases like that of Daniel Vasella, the former chief executive of the pharmaceutical company Novartis, who this year demanded a $78 million severance package in return for a promise not to share his know-how with any competitors. [read post]
28 Nov 2013, 5:00 am
Novartis Pharmaceuticals Corp., ___ F. [read post]